(Q33416332)

English

Selective Bcl-2 inhibition to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Selective Bcl-2 inhibition to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

author name string

Samuel Y Ng

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Matthew S Davids

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical advances in hematology & oncology : H & O

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

224-229

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33416332&oldid=1947430922"